*Kai Sato1, Suzuki-Utsunomiya Kyoko1, Mitsui Shun1, Ono Suzuka1, Shimakura Kento1, Otomo Asako1,2, Hadano Shinji1,2 (1. Dept Mol Life Sci, Tokai Univ Sch of Med, Kanagawa, Japan, 2. Micro/Nano Technology Center, Tokai Univ, Kanagawa, Japan)
Session information
Oral
[3O10m-2] ALS/Tauopathy
Fri. Jul 31, 2020 10:00 AM - 11:00 AM Room 10
*Videos are available throughout the meeting period.
*Masahiko Takahashi1, Hiroki Kitaura2, Akiyoshi Kakita2, Taichi Kakihana1, Yoshinori Katsuragi1, Akihide Koyama3,4, Osamu Onodera4, Yuriko Iwakura5, Hiroyuki Nawa5, Masaaki Komatsu6, Masahiro Fujii1 (1. Div Virology, Niigata Univ Grad Sch of Medical and Dental Sciences, Niigata, Japan, 2. Dept Pathology, Brain Research Inst, Niigata Univ, Niigata, Japan, 3. Div Legal Medicine, Niigata Univ Grad Sch of Medical and Dental Sciences, Niigata, Japan, 4. Dept Neurology, Brain Research Inst, Niigata Univ, Niigata, Japan, 5. Dept Molecular Neurobiology, Brain Research Inst, Niigata Univ., Niigata, Japan, 6. Dept Physiol, Juntendo Univ Sch of Medicine, Tokyo, Japan)
*MASAFUMI SHIMOJO1, Hiroyuki Takuwa1, Yuhei Takado1, Masaki Tokunaga1, Satoshi Tsukamoto2, Keiichiro Minatohara1, Maiko Ono1, Chie Seki1, Jun Maeda1, Takuya Urushihata1, Takeharu Minamihisamatsu1, Ichio Aoki3, Kazunori Kawamura4, ming-rong Zhang4, Tetsuya Suhara1, Naruhiko Sahara1, Makoto Higuchi1 (1. Department of Functional Brain Imaging, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan, 2. Laboratory Animal and Genome Sciences Section, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan, 3. Department of Molecular Imaging and Theranostics, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan, 4. Department of Radiopharmaceuticals Development, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan)
*DAIJIRO YANAGISAWA1, Hamizah Shahirah Hamezah1, Aslina Pahrudin Arrozi1, Ikuo Tooyama1 (1. MNRC, Shiga Univ Med Sci)